An Exploratory Study to Identify Potential Surrogate Endpoint Biomarke-261995139

Abstract

Funding Agency

Agency: National Institute of Health (NIH)
Institute: National Cancer Institute (NCI)
Type: Research and Development Contracts (N01)
Project #: N01CA095139-006
Application #: 6828935
Study Section

Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year: 2003
Total Cost
Indirect Cost

Institution

Name: University of Texas Sw Medical Center Dallas
Department
Type
DUNS #

City
State
Country
Zip Code

Related projects


NIH 2006 N01 CA	An Exploratory Study to Identify Potential Surrogate Endpoint Biomarke-261095139 / University of Texas Sw Medical Center Dallas
NIH 2003 N01 CA	An Exploratory Study to Identify Potential Surrogate Endpoint Biomarke-261995139 / University of Texas Sw Medical Center Dallas
NIH 2002 N01 CA	An Exploratory Study to Identify Potential Surrogate Endpoint Biomarke-261995139 / University of Texas Sw Medical Center Dallas

Publications

Euhus, David; Bu, Dawei; Xie, Xian-Jin et al. (2011) Tamoxifen downregulates ets oncogene family members ETV4 and ETV5 in benign breast tissue: implications for durable risk reduction. Cancer Prev Res (Phila) 4:1852-62

Comments

Be the first to comment on this grant